重组人源性抗HBsAg Fab抗体的肽质量图谱分析

重组人源性抗HBsAg Fab抗体具有较好的特异性和抗原结合活性,为了更好的阐明毕赤 酵母表达的重组人源性抗HBsAg Fab抗体的性质,用基质辅助激光解析飞行时间质谱(MALDI- TOF-MS)对重组Fab抗体的分子质量和肽质量图谱进行了分析。结果显示,毕赤酵母表达的重组 人源性抗HBsAg Fab抗体的分子质量为50678．49Da,与根据其一级结构计算的理论分子质量相 比多2763．84 Da,显示酵母表达的重组Fab抗体为糖蛋白。用胰蛋白酶酶解重组Fab抗体后进行 MALDI-TOF-MS分析显示,大部分的酶解肽段均能检测出来。结果表明毕赤酵母表达的重组Fab 抗体与预期的结构一致。     

地鳖虫纤溶活性蛋白cDNA序列克隆与毕赤酵母表达

依据已报道的地鳖虫成熟肽cDNA序列设计引物,通过RT-PCR法从地鳖虫(Eupolyphage sinensis Walker)中克隆得到675 bp地鳖虫纤溶活性蛋白 (fibrinolytic protein,EFP)成熟肽编码序列.将此片段克隆到表达载体pPICZα-A中,转化毕赤酵母GS115,甲醇诱导表达得到重组表达蛋白,经SDS-PAGE电泳和活性鉴定,表明重组EFP在毕赤酵母中均获得表达,重组表达蛋白相对分子质量为28.2 kD,表达产物分子质量与理论分子质量相符.重组蛋白在毕赤酵母中以分泌形式表达,具有纤溶活性.     

东方肉座菌EU7-22纤维素内切酶Ⅰ的异源表达

[目的]实现东方肉座菌纤维素内切酶EGⅠ在毕赤酵母中的表达,获得重组EGⅠ。[方法]通过RT-PCR获得EGⅠ开放阅读框。将EGⅠ成熟肽和PHO1信号肽的DNA片段插入p PIC3. 5K后,重组表达载体电转化毕赤酵母。通过甲醇诱导表达和镍柱纯化获得EGⅠ。以羟甲基纤维素钠检测活性,以肽N-糖苷酶F分析N-糖基化,以SDSPAGE分析表达情况和糖基化修饰。[结果]获得EGⅠ分泌表达菌株,诱导96 h后上清液活性为0. 513±0. 002 U/m L,纯化后的EGⅠ活性为0. 558±0. 012 U/mg。SDS-PAGE表明EGⅠ分子量在100～180 k Da,远高于预测值47. 3k Da,经肽N-糖苷酶F处理后,降至63～75 k Da。[结论]实现了EGⅠ的分泌表达,获得活性为0. 558±0. 012 U/mg的糖基化重组EGⅠ。     

重组抗癫痫肽二串体的表达、纯化与鉴定

目的：利用基因工程方法表达抗癫痫肽（AEP）串联体蛋白,并进行纯化、鉴定。方法：PCR扩增AEP及AEP—His基因片段,并分别克隆至测序载体中;测序正确后,利用基因重组技术获得二串体基因,构建毕赤酵母表达载体pPIC9K-AEP2-His,甲醇诱导AEP2-His在毕赤酵母中表达,用Ni—chelating SepharoseFF柱纯化表达的融合蛋白,并用抗His单克隆抗体进行Westernblot鉴定。结果：构建了AEP二串体酵母表达载体,获得了纯化的AEP2-His蛋白,其相对分子质量约20000。结论：用基因串联思路表达小分子多肽是一种可行的方法;AEP2-His蛋白的成功表达为其功能研究奠定了基础。     

单纯疱疹病毒2型糖蛋白D成熟肽基因毕赤酵母表达载体的构建及序列分析

构建单纯疱疹病毒2型包膜糖蛋白D成熟肽基因毕赤酵母表达载体,并对序列进行分析,为进行高抗原性的真核表达重组gD蛋白奠定基础。采用PCR扩增HSV2-gD成熟肽基因,将该段基因克隆于pGEM-T克隆载体,转化鉴定后,与巴斯德毕赤酵母表达载体(pPIC9K)酶切连接,转化大肠杆菌DH5α,筛选测序确定构建了pPIC9K?gD的真核表达载体,对克隆的序列进行分析,预测表达产物的理化特性及抗原性。结果显示,获得的重组的酵母表达载体pPIC9K-gD,测序结果证实为HSV2-gD成熟肽基因,序列分析其高度保守,预测蛋白分子量40.63kD,等电点pI为7.15,包含完整成熟肽分值达1.7的多个抗原决定簇。成功构建了HSV2-gD成熟肽基因的毕赤酵母表达载体。     

甘露聚糖酶基因在毕赤酵母中的表达及酶学性质研究

采用PCR的方法,以枯草芽孢杆菌Bacillus subtilis基因组 DNA 为模板,克隆出甘露聚糖酶MAN的成熟肽编码序列,将其插入巴斯德毕赤酵母Pichia pastoris表达载体pPIC9K中,并位于α-因子信号肽序列的下游,获得重组质粒pPIC9K-MAN。重组质粒线性化后用聚乙二醇法导入毕赤酵母Pichia pastoris菌株GS115中,经大量筛选,获得高效分泌表达甘露聚糖酶的毕赤酵母工程菌株MAN22。将此菌株在5 L发酵罐中进行高密度发酵,测定酶活最高达1102IU /mL,同时对重组甘露聚糖酶的性质进行了初步研究。     

组成型表达重组人C-反应蛋白的毕赤酵母菌株构建

目的:构建组成型表达重组人C-反应蛋白(Recombinant human C-reactive protein,rhCRP)的毕赤酵母工程菌株,表达、纯化rhCRP并鉴定其免疫反应性。方法:将设计合成的rhCRP基因克隆到表达载体pGAPZαA上并转化至毕赤酵母X-33中进行组成型分泌表达,通过His亲和层析柱纯化rhCRP。分别采用SDS-PAGE、Western blot和间接ELISA法检测目的蛋白并鉴定其免疫反应性。结果:重组表达载体pGAPZαA/rhCRP经酶切及DNA测序鉴定构建成功。重组毕赤酵母工程菌株成功组成型表达23kDa的rhCRP,27h即达到最大表达水平,表达量约3mg/L。经一步分离纯化获得纯度为96.58%的rhCRP,经间接ELISA检测表明其具有免疫反应性。结论:成功构建了组成型分泌表达rhCRP的毕赤酵母菌株,为进一步自主研发人CRP检测试剂奠定了基础。     

纯化标签的不同位置对Δ6脂肪酸脱饱和酶异源表达的影响

【背景】目前利用酵母表达系统已鉴定了多种物种中的Δ6脂肪酸脱饱和酶(FADS6)。由于FADS6是一种具有多个跨膜螺旋的膜蛋白,使得其大量表达和纯化具有挑战性。【目的】探索FADS6的高效表达策略,研究纯化标签添加的位置对高山被孢霉FADS6I (Ma FADS6I)重组表达效率的影响。【方法】在毕赤酵母表达载体中插入串联亲和标签HRV 3C-Protein A-His,利用改造后的载体构建带有N端或C端标签的Ma FADS6I表达载体;通过电转化获得毕赤酵母重组表达菌株;利用斑点印迹杂交(DotBlot)、聚丙烯酰胺凝胶电泳(SDS-PolyacrylamideGelElectrophoresis,SDS-PAGE)和免疫印迹(Western Blot)分析重组蛋白的表达水平,并利用气相色谱-质谱(Gas Chromatography-Mass Spectrometry,GC-MS)分析检测Ma FADS6I催化生成的脂肪酸。【结果】通过大量的毕赤酵母转化子筛选,最终获得高效表达Ma FADS6I的毕赤酵母重组菌,证实各转化子的表达具有差异性,Ma FADS6I的C端带有纯化标签较N端更有利于表达。【结论】在Ma FADS6I的C端添加纯化标签比在N端添加更有利于该蛋白在酵母系统中的表达以及底物的转化,为进一步探究FADS6高效表达和结构功能奠定了基础。     

耐热羧肽酶Taq基因在毕赤酵母中的表达

为了获取表达羧肽酶Taq毕赤酵母工程菌,通过密码子优化,依据毕赤酵母密码子偏爱性,在体外合成了栖热水生菌的耐热羧肽酶Taq基因。将该基因克隆到毕赤酵母表达载体p HBM905A上并引入6×His标签,构建了重组质粒p HBM905A-Cpase Taq。将该重组质粒转化毕赤酵母GS115,经1%甲醇诱导表达72 h,酶产量达0.1 mg/m L。对纯化的重组酶进行酶活性分析表明在75℃,p H为7.5时,该酶比酶活性为80 U/mg。本研究首次证明了羧肽酶Taq能在毕赤酵母中有效分泌表达,可以被大量制备,进而为多肽水解为氨基酸奠定工业基础。     

鲑鱼降钙素与骨生长肽融合基因的克隆及其在毕赤酵母中的表达

降钙素 (Calcitonin ,CT)和骨生长肽 (Osteogenicgrowthpeptide ,OGP)是两种治疗骨质疏松症的药物 ,设想通过这两种基因的融合表达来达到治疗骨质疏松的目的。体外合成OGP和sCT的基因 ,经过DNA体外重组构建酵母表达质粒 ,实现了在毕赤酵母中的表达 ,通过纯化后进行氨基酸N端测序 ,证明表达的蛋白序列正确。     

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

正Dear Editor,In December 2019, a novel human coronavirus caused an epidemic of severe pneumonia(Coronavirus Disease 2019,COVID-19) in Wuhan, Hubei, China(Wu et al. 2020; Zhu et al. 2020). So far, this virus has spread to all areas of China and even to other countries. The epidemic has caused 67,102 confirmed infections with 1526 fatal cases     

Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active site

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.     

The structure, reproduction and taxonomy of Vidalia and Osmundaria (Rhodophyta, Rhodomelaceae)

Comprises species occurring mostly in subtidal habitats in tropical, subtropical and warm-temperate areas of the world. An analysis of the type species, V. spiralis (Sonder) Lamouroux ex J. Agardh, a species from Australia, establishes basic characters for distinguishing species in the genus. These characters are (1) branching patterns of thalli, (2) flat blades that may be spiralled on their axis, (3) width of the blade, (4) primary or secondary derivation of sterile and fertile branchlets and (5) position of sterile and fertile branchlets on the thalli. Application of the latter two characters provides an important basic method for separation of species into three major groups. Osmundaria , a genus known only in southern Australia, was studied in relation to Vidalia , and its separation from the Vidalia assemblage is not accepted. Species of Vidalia therefore are transferred to the older genus name, Osmundaria. Two new species, Osmundaria papenfussii and Osmundaria oliveae are described from Natal. Confusion in the usage of the epithet, Vidalia fimbriala Brown ex Turner has been clarified, and Vidalia gregaria Falkenberg, described as an epiphyte on Osmundaria pro/ifera Lamouroux, is revealed to be young branches of the host, Osmundaria prolifera.     

New or rare chromosome counts in Artemisia L. (Asteraceae, Anthemideae) and related genera from Kazakhstan

Fifteen chromosome counts of six Artemisia taxa and one species of each of the genera Brachanthemum, Hippolytia, Kaschgaria, Lepidolopsis and Turaniphytum are reported from Kazakhstan. Three of them are new reports, two are not consistent with previous counts and the remainder are confirmations of very scarce (one to four) earlier records. All the populations studied have the same basic chromosome number, x = 9, with ploidy levels ranging from 2x to 6x. Some correlations between ploidy level, morphological characters and distribution are noted.     

肝癌中HBV和HCV基因和抗原的分布及意义

采用原位分子杂交方法检测HCV RNA及HBV X基因;采用免疫组织化学方法研究HCV核心抗原,非结构区C33c抗原及HBxAg在肝细胞肝癌中的定位及分布.结果表明(1)HCV RNA、HBV X基因在肝细胞肝癌组织检出率分别为40%(55/136)和82%(112/136).HCV RNA定位于癌细胞的胞浆内,阳性细胞呈散在、灶状及弥漫分布三种形式;HBV X基因在肝癌细胞中的分布呈胞浆型、核型及核浆型,阳性细胞也呈上述三种分布形式;(2)HCV C33c抗原、核心抗原在肝细胞肝癌中的阳性率为81%(133/164)及86%(141/164).C33c抗原定位于癌细胞及肝细胞的胞浆内;核心抗原既定位于癌细胞核中,又可定位于胞浆中.C33c抗原阳性细胞以灶状分布为主;而核心抗原阳性细